Masahito Nagashima

A narrative review on drug development for the management of antimicrobial- resistant infection crisis in Japan: the past, present, and future

K. Tateda, N. Ohmagari, Takahisa Ohashi, 2022, Expert review of anti-infective therapy.

Antifungal susceptibilities of Candida species isolated from the patients with vaginal candidiasis.

H. Mikamo, Y. Yamagishi, Masahito Nagashima, 2016, Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy.

Efficacy and safety of a single oral 150 mg dose of fluconazole for the treatment of vulvovaginal candidiasis in Japan.

H. Mikamo, Y. Nakazuru, Akifumi Okayama, 2015, Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy.

Contradiction between in vitro and clinical outcome: intravenous followed by oral azithromycin therapy demonstrated clinical efficacy in macrolide-resistant pneumococcal pneumonia.

K. Tateda, S. Kohno, J. Kadota, 2014, Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy.

Efficacy and safety of metronidazole injection for the treatment of infectious peritonitis, abdominal abscess and pelvic inflammatory diseases in Japan.

H. Mikamo, Y. Nakazuru, Masahito Nagashima, 2015, Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy.

Criteria for safety evaluation of antimicrobial agents

K. Yanagihara, Norifumi Yamamoto, F. Higa, 2011, Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy.

Efficacy and safety of monotherapy by pegvisomant, a growth hormone receptor antagonist, in Japanese patients with acromegaly.

K. Chihara, A. Shimatsu, Satoshi Hashigaki, 2016, Endocrine journal.

Association between future events of brain infarction and soluble levels of intercellular adhesion molecule-1 and C-reactive protein in patients with type 2 diabetes mellitus.

E. Nakashima, J. Nakamura, Y. Hamada, 2008, Diabetes research and clinical practice.

Soluble adhesion molecules and C-reactive protein in the progression of silent cerebral infarction in patients with type 2 diabetes mellitus.

J. Nakamura, Y. Hamada, T. Sano, 2006, Metabolism: clinical and experimental.